Back to Search
Start Over
EIF2AK3 variants in Dutch patients with Alzheimer's disease
- Source :
- Neurobiology of Aging: age-related phenomena, neurodegeneration and neuropathology, 73, Neurobiology of aging, Neurobiology of aging 73, 229.e11-229.e18 (2019). doi:10.1016/j.neurobiolaging.2018.08.016, Neurobiology of Aging, 73, 229.e11. Elsevier Inc., Neurobiology of Aging, 73, 229.e11-229.e18. Elsevier Inc., Neurobiology of Aging, 73:229.e11. Elsevier Inc., Wong, T H, van der Lee, S J, van Rooij, J G J, Meeter, L H H, Frick, P, Melhem, S, Seelaar, H, Ikram, M A, Rozemuller, A J, Holstege, H, Hulsman, M, Uitterlinden, A, Neumann, M, Hoozemans, J J M, van Duijn, C M, Rademakers, R & van Swieten, J C 2019, ' EIF2AK3 variants in Dutch patients with Alzheimer's disease ', Neurobiology of Aging, vol. 73, pp. 229.e11-229.e18 . https://doi.org/10.1016/j.neurobiolaging.2018.08.016
- Publication Year :
- 2019
-
Abstract
- Next-generation sequencing has contributed to our understanding of the genetics of Alzheimer's disease (AD) and has explained a substantial part of the missing heritability of familial AD. We sequenced 19 exomes from 8 Dutch families with a high AD burden and identified EIF2AK3, encoding for protein kinase RNA-like endoplasmic reticulum kinase (PERK), as a candidate gene. Gene-based burden analysis in a Dutch AD exome cohort containing 547 cases and 1070 controls showed a significant association of EIF2AK3 with AD (OR 1.84 [95% CI 1.07-3.17], p-value 0.03), mainly driven by the variant p.R240H. Genotyping of this variant in an additional cohort from the Rotterdam Study showed a trend toward association with AD (p-value 0.1). Immunohistochemical staining with pPERK and peIF2 alpha of 3 EIF2AK3 AD carriers showed an increase in hippocampal neuronal cells expressing these proteins compared with nondemented controls, but no difference was observed in AD noncarriers. This study suggests that rare variants in EIF2AK3 may be associated with disease risk in AD. (C) 2018 The Authors. Published by Elsevier Inc.
- Subjects :
- 0301 basic medicine
Oncology
Male
Exome sequencing
Aging
Candidate gene
genetics [Alzheimer Disease]
metabolism [Hippocampus]
Disease
Hippocampus
Whole Exome Sequencing
eIF-2 Kinase
Rotterdam Study
0302 clinical medicine
Missing heritability problem
EIF2AK3
Non-U.S. Gov't
Exome
Netherlands
EIF2AK3 protein, human
General Neuroscience
Research Support, Non-U.S. Gov't
metabolism [eIF-2 Kinase]
Middle Aged
Alzheimer's disease
genetics [Genetic Variation]
eIF-2 Kinase/genetics
Genetic Variation/genetics
Female
Risk
PERK
medicine.medical_specialty
Neuroscience(all)
Hippocampus/metabolism
Clinical Neurology
Research Support
03 medical and health sciences
Alzheimer Disease
Internal medicine
medicine
Journal Article
Humans
ddc:610
Genotyping
Genetic Association Studies
Aged
Alzheimer Disease/genetics
genetics [eIF-2 Kinase]
business.industry
Genetic Variation
Ageing
030104 developmental biology
Neurology (clinical)
Human medicine
Geriatrics and Gerontology
business
030217 neurology & neurosurgery
Developmental Biology
Subjects
Details
- Language :
- English
- ISSN :
- 01974580
- Database :
- OpenAIRE
- Journal :
- Neurobiology of Aging: age-related phenomena, neurodegeneration and neuropathology, 73, Neurobiology of aging, Neurobiology of aging 73, 229.e11-229.e18 (2019). doi:10.1016/j.neurobiolaging.2018.08.016, Neurobiology of Aging, 73, 229.e11. Elsevier Inc., Neurobiology of Aging, 73, 229.e11-229.e18. Elsevier Inc., Neurobiology of Aging, 73:229.e11. Elsevier Inc., Wong, T H, van der Lee, S J, van Rooij, J G J, Meeter, L H H, Frick, P, Melhem, S, Seelaar, H, Ikram, M A, Rozemuller, A J, Holstege, H, Hulsman, M, Uitterlinden, A, Neumann, M, Hoozemans, J J M, van Duijn, C M, Rademakers, R & van Swieten, J C 2019, ' EIF2AK3 variants in Dutch patients with Alzheimer's disease ', Neurobiology of Aging, vol. 73, pp. 229.e11-229.e18 . https://doi.org/10.1016/j.neurobiolaging.2018.08.016
- Accession number :
- edsair.doi.dedup.....d998571165f3a9551e498e41c781ad8d
- Full Text :
- https://doi.org/10.1016/j.neurobiolaging.2018.08.016